Comparative effectiveness of high (above 12CH) and low (below 12CH) potencies of individualized homeopathic medicines in treatment of psoriasis vulgaris: A multi-centric, double-blind, randomized trial - Nil

ehru Homoeopathic Medical College & Hospital, Govt. of NCT of Delh0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•1.Cases suffering from psoriasis vulgaris (ICD-10-CM diagnosis code L40.0) mainly affects mainly trunk and the extensor surfaces of the limbs and scalp for at least 3 months
•2.Psoriasis of mild (PASI < 7, DLQI < 7) to moderate severity (PASI 7-15, DLQI 5-15; may be classified as severe when difficult-to-treat sites are affected or when there is a significant psychosocial impact)
•3.Had not taken any treatment for the past 2 weeks
•4.Those aged between 18 and 65 years
•5.Participants of either sex
•6.Literate patients who can read English, Hindi and/or Bengali. Illiterate participants will be interviewed by the investigators maintaining adequate privacy

•1.Suffering from severe psoriasis (PASI > 15, independent of DLQI score)
•2.Suffering from guttate, pustular, erythrodermic and annular varieties of psoriasis
•3.Similar looking skin conditions â?? atopic and contact dermatitis, lichen planus, secondary syphilis, mycosis fungoides, tinea corporis, pityriasis rosea, etc.
•4.Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill subjects.
•5.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
•6.Pregnant and puerperal women, lactating mothers
•7.Tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence
•8.Self-reported immune-compromised state (e.g., HIV)
•9.Undergoing homeopathic treatment for any chronic disease(s) within last 6 months
•10.Simultaneous participation in any other clinical trial

发起方

ehru Homoeopathic Medical College & Hospital, Govt. of NCT of Delh